Loading...
NPI 1073568788 · New York, NY · Diagnostic Radiology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Patrick Kang is a diagnostic radiology physician provider located in New York, New York. This profile covers 23 Medicare and 3 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Patrick Kang |
| Address | 140 4th Ave |
| City | New York |
| State | NY |
| ZIP | 10003 |
| Taxonomy | Diagnostic Radiology Physician |
| NPI Enumerated | May 23, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $804.7K |
| Medicaid | $74.6K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
23 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 290 | $1,520 | $446.3K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 320 | $420 | $136.3K |
| 71271 | The provider performs a low–dose computed tomography (LDCT), with low–dose ionizing radiation, for examination of the thorax without using contrast material to screen for lung cancer. | 280 | $170 | $47.5K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 20 | $1,580 | $37.9K |
| A9584 | Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | 20 | $1,940 | $29K |
| 78306 | The provider performs a bone scan (also known as scintigraphy), a specialized nuclear medicine procedure in which the provider injects a radionuclide prior to imaging to examine the various bones of… | 80 | $230 | $19.3K |
| 78608 | In this diagnostic procedure, the provider performs PET, positron emission tomography, a type of nuclear imaging test. It tells how the brain is functioning with information on metabolism, such as… | 10 | $1,390 | $18K |
| 78227 | The provider images the liver, bile, bile ducts, and gallbladder to follow the production and flow of bile from the liver to the small intestine to diagnose a bile duct obstruction or leakage;… | 20 | $380 | $8K |
| 78071 | The provider performs a SPECT study to image the parathyroid glands, also taking sets of planar images after administering very small amounts of two different radiopharmaceuticals or radioactive… | 30 | $290 | $7.6K |
| 71250 | In this diagnostic procedure, the provider performs a computed tomography, or CT, examination of the thorax without using contrast material. | 60 | $130 | $7.3K |
Showing 1–10 of 23
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
23 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 78815 | 51 | 330 | 80 | $690 | $116.6K |
| 78608 | 22 | 30 | 40 | $640 | $62.4K |
| A9552 | 16 | 200 | 60 | $350 | $42.8K |
| A9584 | 5 | 10 | 20 | $1,970 | $37.5K |
| 78816 | 88 | 140 | 40 | $590 | $31.8K |
| A9500 | 347 | 380 | 130 | $90 | $15.9K |
| 74177 | 1,305 | 1,350 | 110 | $100 | $14.8K |
| 71250 | 757 | 1,300 | 80 | $60 | $9.1K |
| A9541 | 4 | 10 | 20 | $220 | $5.3K |
| 71260 | 1,017 | 1,120 | 60 | $50 | $5K |
Showing 1–10 of 23
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 340 | $150 | $50.6K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 400 | $60 | $24.2K |
| 71046 | In this diagnostic procedure, the provider performs a minimum of two radiological views of the chest. He performs this study for the assessment of conditions affecting the chest, its contents, and… | 20 | $10 | $80 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
3 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 32 | 110 | 80 | $570 | $236.2K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 20 | 70 | 90 | $150 | $72.3K |
| 71046 | In this diagnostic procedure, the provider performs a minimum of two radiological views of the chest. He performs this study for the assessment of conditions affecting the chest, its contents, and… | 1,371 | 1,510 | 230 | $10 | $28.7K |
Other providers in the same ZIP code as Patrick Kang, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Home Health Management Services, Inc. | NY | Home Health Agency | $0 | $85.7M |
| New York Eye & Ear Infirmary | NY | Special Hospital | $0 | $38.9M |
| Nyu Langone Hospitals | NY | General Acute Care Hospital | $0 | $32.2M |
| Realization Center, Inc. | NY | Clinic/Center | $0 | $27.2M |
| Gpddc, LLC | NY | Ambulatory Surgical Clinic/Center | $401.4K | $11.7M |
| Jonathan Feistmann | NY | Ophthalmology Physician | $2.7M | $3.1M |
| Louis Angioletti | NY | Retina Specialist (Ophthalmology) Physician | $2.2M | $31.6K |
| Navin Mehta | NY | Ophthalmology Physician | $460K | $875.8K |
| Alan Dayan | NY | Retina Specialist (Ophthalmology) Physician | $838.6K | $226.1K |
| Wen Fan | NY | Anatomic Pathology & Clinical Pathology Physician | $1.1M | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.